ABCC1 and pachyonychia congenita: In addition, when a combination of TAOK3 and ABCC1 were used, the prediction of recurrence-free survival of PC patients using Taylor et al. data was significant (p = 0.00042, Concordance Index = 70.75, Risk Groups Hazard Ratio = 3.91) (Supplementary Figure 2).